Green Thumb Industries Inc. (GTBIF) Stock Price & Analysis
Green Thumb Industries Inc. (GTBIF) fell 2.63% to USD 8.51 as of June 10, 2026 at 00:56 UTC, according to Nexqual real-time market data.
GTBIF last closed at USD 8.74; the session ranged USD 8.47–9.3 on volume of 305,145 shares. Market capitalization is $1.86B, with a 52-week range of USD 4.8–10.43 (OQX). Source: Nexqual, June 10, 2026 at 00:56 UTC.
Key Statistics (as of June 10, 2026 at 00:56 UTC)
| Price | USD 8.51 |
|---|---|
| Change | ▼ 2.63% (down) |
| Previous Close | USD 8.74 |
| Open | USD 8.75 |
| Day Range | USD 8.47 – 9.3 |
| 52-Week Range | USD 4.8 – 10.43 |
| Volume | 305,145 shares |
| Market Cap | $1.86B |
| Exchange | OQX |
Technical Analysis (GTBIF)
Nexqual's technical model rates GTBIF "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 10, 2026 at 00:56 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 58.06 (neutral) |
| vs SMA50 | Above (USD 7.44) |
| MACD | 0.26 (positive) |
Analyst Ratings (GTBIF)
Wall Street analysts rate GTBIF "None" based on 3 analysts, with a mean price target of USD 15.67 (range USD 10–20), per Nexqual as of June 10, 2026 at 00:56 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 15.67 |
| High Target | USD 20 |
| Low Target | USD 10 |
| Buy / Hold / Sell | 9 / 0 / 0 |
Earnings (GTBIF)
| Next Earnings Date | 2026-08-05 |
|---|---|
| EPS Estimate | USD -0.01 |
| Revenue Estimate | $299.07M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.04 vs est -0.02 ▲ beat |
| 2025-12-31 | USD 0.03 vs est -0.01 ▲ beat |
| 2025-09-30 | USD 0.1 vs est 0.04 ▲ beat |
| 2025-06-30 | USD 0.05 vs est 0.03 ▲ beat |
Source: Nexqual, June 10, 2026 at 00:56 UTC.
Financials & Fundamentals (GTBIF)
| Total Revenue | $1.20B |
|---|---|
| Revenue Growth (YoY) | +7.40% |
| Gross Margin | +48.10% |
| Operating Margin | +13.57% |
| Profit Margin | +10.14% |
| ROE | +6.63% |
| Debt / Equity | 29.64 |
| Current Ratio | 3.47 |
| Total Cash | $344.51M |
| Total Debt | $562.37M |
| Free Cash Flow | $146.94M |
Source: Nexqual, June 10, 2026 at 00:56 UTC.
Financial Health Score (GTBIF)
Nexqual rates Green Thumb Industries Inc.'s overall financial health "Solid" across five dimensions, as of June 10, 2026 at 00:56 UTC.
| Growth | Mixed — Revenue +3.4% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 48%, operating 14% |
| Balance Sheet | Strong — $345M cash vs $562M debt |
| Cash Flow | Solid — FCF $147M, 13% margin |
| Efficiency | Mixed — ROE 7%, ROA 3.1% |
Ownership (GTBIF)
| Insider Ownership | +1.70% |
|---|---|
| Institutional Ownership | +8.21% |
| Shares Outstanding | 195.07M |
| Float | 189.97M |
Source: Nexqual, June 10, 2026 at 00:56 UTC.
Leadership (GTBIF)
Green Thumb Industries Inc. is led by Benjamin Kovler (age 46), Founder, Chairman & CEO, per Nexqual as of June 10, 2026 at 00:56 UTC.
| Founder, Chairman & CEO | Benjamin Kovler (age 46) |
|---|---|
| President & Director | Anthony Georgiadis (age 47) |
| Chief Financial Officer | Mathew Faulkner (age 51) |
| President of Operations | Matt Navarro |
| Senior Vice President of Technology | Josh Barrington |
From Green Thumb Industries Inc.'s Latest SEC 10-K Filing (filed 2026-02-25)
Key Strengths & Strategy (as disclosed to the SEC)
- The Company also licenses certain intellectual property to and from third parties for the manufacture and sale of consumer products.   As the Company became licensed to cultivate cannabis, we have developed proprietary cultivation techniques.
- Adult-use cannabis became legal in Massachusetts as of December 15, 2016, following a ballot initiative in November 2016.   Massachusetts Licenses and Regulations   There is one principal medical cannabis license category in Massachusetts: a vertically integrated Medical Marijuana Treatment Center ("MTC") license.
- License types in New Jersey include vertically integrated medical Alternative Treatment Centers and medical or adult-use cultivator, dispensary, and manufacturer licenses.   We are licensed to operate two adult-use/medical cultivation facilities, one of which is co-located with a processing facility, one retail medical cannabis dispensary and two retail adult-use/medical dispensaries in the state of New Jersey.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CURLD | Curaleaf Holdings, Inc. | USD 10.83 | ▼ 5.91% |
| TCNNF | Trulieve Cannabis Corporation | USD 11.58 | ▼ 1.36% |
| CRLBF | Cresco Labs Inc. | USD 0.9 | ▼ 0.43% |
| GRWG | GrowGeneration Corp. | USD 1.59 | ▼ 1.24% |
| IIPR | Innovative Industrial Propertie | USD 60.34 | ▲ 3.04% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:56 UTC. This page is informational and not investment advice.